Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial
在住院 COVID-19 患者中，使用血管紧张素 II 2 型受体激动剂 C21 进行为期 7 天的治疗；一项安慰剂对照、随机、多中心、双盲 II 期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2021.101152
Tornling, Göran; Batta, Rohit; Porter, Joanna C; Williams, Bryan; Bengtsson, Thomas; Parmar, Kartikeya; Kashiva, Reema; Hallberg, Anders; Cohrt, Anne Katrine; Westergaard, Kate; Dalsgaard, Carl-Johan; Raud, Johan
